Stay updated with breaking news from Vicki goodman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Now we kickoff the weekend with a report on required reading for College Freshman. If we dont have enough people go out and find some. [inaudible conversations] welcome to the National Association of scholars. I am peter wyatt wood, president of the National Association of scholars. In 2009, a young man heading on vacation in mexico picked up and unusually heavy book for his beach reading, and 800 page tome of the life of an 18thcentury immigrant. 50 pages or so into the book the story took possession of the 29yearold. Would emerge from his reading of Alexander Hamilton is now the hottest ticket on broadway, the hiphop musical hamilton. Broadways play is widely noted for many things including its exact fidelity to historical facts. Each bowl must n ....
American media and the welltuned brain, which is the book that dr. Peter whybrow will be talking about this evening. Welcome, dr. Whybrow. Thank you so much for coming to speak with us this evening. This is a real treat for so many of us. We even have people here from oxford, from france, and we are just delighted to welcome you this evening. Joining dr. Whybrow in discussion will be another preeminent scientist from the institute, dr. Andrew loopter who is a professor of psychiatry and Biobehavioral Sciences and the director of the Neuromodulation Center at the Semel Institute. Hes also our faculty adviser. So we would like to thank dr. Luketer also for being here this evening and for sharing his knowledge and expertise with us. A few housekeeping items. After the presentation we will have a discussion. ....
Woodcock set to retire from FDA in early 2024—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Mural Oncology Launches To Advance Pipeline Of Novel Engineered Cytokine Immunotherapies menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Mural Oncology plc spins out from Alkermes plc with $275 million in committed funding, providing a cash runway projected into 4Q 2025 Company’s lead product candidate – nemvaleukin alfa – being developed to treat a wide range of solid tumors – is currently in two potentially registrational clinical trials, both with readouts expected in 1Q 2025 Mural is also advancing engineered therapies targeting interleukin-18 and interleukin-12 with plans to nominate a development candidate for each program ....